Skip to content

Effects of Hypercapnia on Emergence From General Anesthesia Under Propofol

Effects of Hypercapnia on Emergence From General Anesthesia Under Propofol: a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01531491
Enrollment
30
Registered
2012-02-13
Start date
2012-01-31
Completion date
2013-06-30
Last updated
2015-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Intravenous, Anesthesia Recovery Period

Keywords

Emergence, Hypercapnia, Hypocapnia, Propofol

Brief summary

Hypercapnia derives increase of cerebral blood flow and cardiac output. It means that the rate of propofol elimination from the brain and the blood will be increased and the patient will awake more quickly. There has been no study about the effects of hypercapnia. The investigators will evaluate hypercapnia's effects on the recovery time from propofol anesthesia.

Interventions

PROCEDURERebreathing tube

750 ml rebreathing tube will be connected between the corrugated tube and the tracheal tube of a patient. Target partial pressure of the end-tidal carbon dioxide is 50 mmHg.

PROCEDURENo rebreathing tube (Nothing)

750 ml rebreathing tube will not be connected between the corrugated tube and the tracheal tube of a patient. Target partial pressure of the end-tidal carbon dioxide is 30 mmHg.

Sponsors

DongGuk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists physical status (ASA PS) I-II * Age 20 - 60 years male and female * Elective schedule with minor surgery under general anesthesia

Exclusion criteria

* Body mass index (BMI) \>= 30 (kg/m2) * Patient with pulmonary, cardiac, endocrinal, neuromuscular and neurological diseases or past history * Patient with medication affecting on this study * Patient with general anesthesia history within one month

Design outcomes

Primary

MeasureTime frameDescription
Time to open eyes under investigator's commandFrom cessation of propofol infusion to patient's eye opening (seconds)After stopping propofol infusion, every 30 seconds, the investigator (caregiver) will command the patient, Open your eyes. When the patient opens eyes, the time will be recorded. The patients will be followed for an expected average of 10 minutes.

Secondary

MeasureTime frameDescription
Time to breath spontaneouslyFrom cessation of propofol infusion to patient's spontaneous breathing (sec)The time from cessation of propofol infusion to patient's spontaneous breaths will be recorded. The patients will be followed for an expected average of 10 minutes.
Change of bispectral index (BIS)From the cessation of propofol infusion to extubation, BIS and time (seconds) will be recorded.After stopping propofol infusion, the BIS and time (seconds) will be recorded and reviewed. These will be recorded for an expected average of 15 minutes.
Time to open mouth under investigator's commandFrom cessation of propofol infusion to patient's mouth opening (seconds)After the patient opens the eyes, every 10 seconds, the investigator command the patient, Open your mouth.. When the patient opens mouth, the time will be recorded. The patients will be followed for an expected average of 12 minutes.
Time to extubationFrom cessation of propofol infusion to extubation (sec)After stopping propofol infusion, When the patient breaths spontaneously with adequate tidal volume and respiratory rates, the trachea will be extubated and the time will be recorded. The patients will be followed for an expected average of 15 minutes.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026